The effect of macroprolactinemia on gonadotropin secretion

Endocrinologist

Volumn 17, Issue 6, 2007, Pages 346-350

  Tamer, Gonca ^a   Telci, Aysegül ^b   Aral, Ferihan ^a   Yarman, Sema ^a   Özbey, Nese ^a   Boztepe, Harika ^a   Alagöl, Faruk ^a,c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Gonadal dysfunction; Hyperprolactinemia; Macroprolactinemia

Indexed keywords

MONOMERIC PROLACTIN; PROLACTIN; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CLINICAL EVALUATION; ESTRADIOL BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; HORMONE ACTION; HUMAN; INFERTILITY; LUTEINIZING HORMONE BLOOD LEVEL; MACROPROLACTINEMIA; MENSTRUAL IRREGULARITY; PATIENT ASSESSMENT; PROLACTIN BLOOD LEVEL; RANK SUM TEST; REVIEW;

EID: 37349065066     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/TEN.0b013e31815ae8fb     Document Type: Review

References (22)

1. Strachan MWJ, Teoth WL, Don-Wauchopet AC, et al. Clinical and radiological features of patients with macroprolactinaemia. Clin Endocrinol. 2003;59:339-346.
2. Sanchez-Eixeres MR, Mauri M, Alfayete R, et al. Prevalence of macroprolactin detected by Elecsys 2010. Horm Res. 2001;56:87-92.
3. Diver MJ, Ewins DL, Worth RC, et al. An unusual form of big big (macro) prolactin in a pregnant patient. Clin Chem. 2001;47:347-349.
4. Leanos-Miranda A, Pascoe-Lira D, Chavez-Rueda KA, et al. Persistence of macroprolactinaemia due to antiprolactin autoantibody before, during and after pregnancy in a woman with systemic lupus erythematosus. J Clin Endocrinol Metab. 2001;86:2619-2624.
5. Schneider W, Marcovitz S, Al-Shammari S, et al. Reactivity of macroprolactin in common automated immunoassays. Clin Biochem. 2001;34: 469-473.
6. Smith TP, Suliman AM, Fahie-Wilson MN, et al. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab. 2002;87: 5410-5415.
7. Suliman AM, Smith TP, Gibney J, et al. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening application of a new strict laboratory definition of macroprolactinaemia. Clin Chem. 2003;49:1504-1509.
8. Jackson RD, Worstman J, Malarkey WB. Macroprolactinemia presenting like a pituitary tumor. Am J Med. 1985;78:346-350.
9. Leanos-Mitand A, Chaves-Rueda KA, Blanco-Favela F. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44:866-875.
10. Olukago AO. Macroprolactinemia is clinically important. J Clin Endocrinol Metab. 2002;87:4833-4834.
11. Hattori N, Ikekubo K, Islihara T, et al. Effects of antiprolactin autoantibodies on serum prolactin measurements. Eur J Endocrinol. 1994;130: 434-437.
12. Olukago AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol. 1999;51:119-126.
13. Hauache OM, Rocha AJ, Maia ACM, et al. Screening for macroprolactinaemiae and pituitary imaging studies. Clin Endocrinol. 2002;57:327-331.
14. Cattaeo FA, Fahie-Wilson MN. Concomitant occurrence of macroprolactin exercise-induced amenorrhea and a pituitary lesion: a diagnostic pitfall. J Neurosurg. 2001;95:334-337.
15. Amadori P, Dilberis C, Marcollo A, et al. Macroprolactinaemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods. J Endocrinol Invest. 2003;26:148-156.
16. Molitch ME, Russel EJ. The pituitary "incidentaloma." Ann Intern Med. 1990;112:925-931.
17. Vallette-Kasic S, Morange-Ramos I, Selim A, et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab. 2002;87:581-588.
18. Soong YK, Ferguson KM, McGarrick G, Jeffcoate SL. Size heterogeneity of immunoreactive prolactin in hyperprolactinaemic serum. Clin Endocrinol (Oxf). 1982;16:259-265.
19. Tritos NA, Guay TA, Malarkey WB. Asymptomatic "big" hyperprolactinemia in two men with pituitary adenomas. Eur J Endocrinol. 1998;138:82-85.
20. Buvat J, Lemaire A, Buvat-Herbaut M, et al. Hyperprolactinemia and sexual function in men. Horm Res. 1985;22:196-203.
21. Fahie-Wilson MN, Soule SG. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem. 1999;34:252-258.
22. Nagulesparen M, Ang V, Jenkins JS. Bromocriptine treatment of males with pituitary tumours, hyperprolactinemia and hypogonadism. Clin Endocrinol. 1978;9:73-79.